Design, synthesis, and structural analysis of influenza neuraminidase inhibitors containing pyrrolidine cores

被引:133
作者
Wang, GT
Chen, YW
Wang, S
Gentles, R
Sowin, T
Kati, W
Muchmore, S
Giranda, V
Stewart, K
Sham, H
Kempf, D
Laver, WG
机构
[1] Abbott Labs, Div Pharmaceut Prod, Abbott Pk, IL 60064 USA
[2] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 260, Australia
关键词
D O I
10.1021/jm000468c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery of (+/-)-(2S,3R,4R)-2-(trifluoroacetamido)methyl-3-amino-1-(N ' -ethyl-N ' -isopropylcarbamyl)pyrrolidine-4-earboxylic acid (A-192558, 20e) as a potent inhibitor of influenza neuraminidase (NA) is described. Efficient syntheses of two core structures, cis-3-(allyloxy-carbonyl)amino-1-(9 ' -fluorenylmethoxycarbonyl)pyrrolidine-4-carboxylic acid (7) and tert-butyl (+/-)(2S, 3R,4R)-2-aminomethyl-3-bis(tert-butyloxycarbonyl) amino-1-(N ' -ethyl-N ' -isopropylcarbamyl)pyrrolidine-4-carboxylate (18b), were developed. Starting with these core structures and using available structural information of the NA active site as the guide, analogues were synthesized in both the tri- and tetrasubstituted pyrrolidine series by means of high-throughput parallel synthesis in solid or solution phase for expeditious SAR. These studies accelerated the identification of(+/-)-(2S,3R,4R)-2-(trifluoroacetamido)methyl-3-amino-1-(N-ethyl-N-isopropylcarbamyl)pyrrolidine-4-carboxylate (20e, A-192558) as the most potent NA inhibitor in this series (IC50 = 0.2 muM against NA A and 8 muM against NA B). The X-ray crystallographic structure of A-192558 bound to NA revealed the predicted interaction of the carboxylic group with the positively charged pocket (Arg118, Arg292, Arg371) and interaction of the trifluoro-acetamino residue with the hydrophobic pocket (Ile222, Trp178) of the enzyme active site. Surprisingly, the ethyl and isopropyl groups of the urea functionality induced a conformational change of Glu276, turning the Glu276/Glu277 hydrophilic pocket, which normally accommodates the triglycerol side chain of substrate sialic acid, into an induced hydrophobic pocket.
引用
收藏
页码:1192 / 1201
页数:10
相关论文
共 43 条
  • [1] THE NEURAMINIDASE OF INFLUENZA-VIRUS
    AIR, GM
    LAVER, WG
    [J]. PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1989, 6 (04): : 341 - 356
  • [2] BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
    Babu, YS
    Chand, P
    Bantia, S
    Kotian, P
    Dehghani, A
    El-Kattan, Y
    Lin, TH
    Hutchison, TL
    Elliott, AJ
    Parker, CD
    Ananth, SL
    Horn, LL
    Laver, GW
    Montgomery, JA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) : 3482 - 3486
  • [3] *BIOS MSI INC, 1994, QUANT MAN
  • [4] BRAMFORD M, 1995, J ENZYME INHIB, V10, P1
  • [5] Brunger AT, 1997, NAT STRUCT BIOL, V4, P862
  • [6] Design and synthesis of benzoic acid derivatives as influenza neuraminidase inhibitors using structure-based drug design
    Chand, P
    Babu, YS
    Bantia, S
    Chu, NM
    Cole, LB
    Kotian, PL
    Laver, WG
    Montgomery, JA
    Pathak, VP
    Petty, SL
    Shrout, DP
    Walsh, DA
    Walsh, GW
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (25) : 4030 - 4052
  • [7] CHEN Y, UNPUB BIOORG MED CHE
  • [8] COLEMAN PM, 1989, INFLUENZA VIRUSES, P175
  • [9] CRENNEL S, 1996, J MOL BIOL, V259, P262
  • [10] GENTLES R, UNPUB J MED CHEM